DRI Healthcare Trust (TSE:DHT.UN) Announces Quarterly Dividend of $0.09

DRI Healthcare Trust (TSE:DHT.UN) declared a quarterly dividend on Friday, June 28th, TickerTech reports. Shareholders of record on Friday, July 19th will be given a dividend of 0.085 per share on Friday, July 19th. This represents a $0.34 annualized dividend and a dividend yield of 2.21%. The ex-dividend date of this dividend is Friday, June 28th. This is a positive change from DRI Healthcare Trust’s previous quarterly dividend of $0.08.

DRI Healthcare Trust Stock Up 39.6 %

Shares of DRI Healthcare Trust stock traded up C$4.36 during trading hours on Thursday, reaching C$15.38. 35,123 shares of the company were exchanged, compared to its average volume of 36,796. DRI Healthcare Trust has a 1 year low of C$10.19 and a 1 year high of C$17.43. The stock’s fifty day moving average is C$15.44 and its 200 day moving average is C$14.76.

Analysts Set New Price Targets

DHT.UN has been the subject of a number of analyst reports. National Bankshares boosted their target price on shares of DRI Healthcare Trust from C$22.00 to C$23.50 and gave the stock an “outperform” rating in a research note on Friday, March 1st. CIBC boosted their target price on shares of DRI Healthcare Trust from C$19.50 to C$20.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Stifel Nicolaus boosted their target price on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Raymond James upgraded shares of DRI Healthcare Trust from an “outperform” rating to a “strong-buy” rating and boosted their target price for the stock from C$22.00 to C$24.00 in a research note on Friday, March 1st. Finally, Canaccord Genuity Group decreased their price objective on shares of DRI Healthcare Trust from C$19.50 to C$19.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of C$21.50.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.